Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Northstar Gold Signs MOU with Hunan Nonferrous Ltd. to Develop Gold Resource (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Viracta Therapeutics Inc VIRX

Healthcare Biotechnology
Viracta Therapeutics, Inc. is a clinical-stage precision oncology company focused on the treatment and prevention of virus-associated cancers, which impact patients worldwide. The Company’s lead product candidate is an all-oral combination therapy of its proprietary investigational drug, nanatinostat, and the antiviral agent valganciclovir (collectively, Nana-val). Nana-val is being evaluated... see more

Recent & Breaking News (NDAQ:VIRX)

SUNESIS INVESTOR ALERT By the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Sunesis Pharmaceuticals, Inc. - SNSS

Business Wire December 29, 2020

SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates the Following Companies - AKER, INFO, SNSS, WORK, WDR

PR Newswire December 19, 2020

SHAREHOLDER ALERT: WeissLaw LLP Reminds NGA, FIII, and SNSS Shareholders About Its Ongoing Investigations

PR Newswire December 18, 2020

SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of INFO, SNSS, INSU, and FBSS Mergers

GlobeNewswire December 17, 2020

INVESTIGATION ALERT: Halper Sadeh LLP Continues to Investigate the Following Companies; Shareholders are Encouraged to Contact the Firm - SNSS, WORK, WDR, ANH

GlobeNewswire December 12, 2020

SHAREHOLDER ALERT: WeissLaw LLP Reminds CLCT, SNSS, WTRE, and STPK Shareholders About Its Ongoing Investigations

PR Newswire December 11, 2020

Viracta Therapeutics Announces Presentation of Updated Phase 2 Data at ASH 2020 and Productive Outcome of its Recent End of Phase 2 Meeting with the FDA

PR Newswire December 7, 2020

ALERT: Halper Sadeh LLP Encourages INFO, SNSS, and WORK Shareholders to Contact the Firm

ACCESSWIRE IA December 5, 2020

SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Sunesis Pharmaceuticals, Inc. - SNSS

PR Newswire December 4, 2020

SUNESIS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Sunesis Pharmaceuticals, Inc. - SNSS

Business Wire December 3, 2020

Halper Sadeh LLP Reminds Shareholders About Its Ongoing Merger Investigations; Investors are Encouraged to Contact the Firm - GV, CLCT, SNSS, WORK

GlobeNewswire December 2, 2020

Moore Kuehn Encourages HDS, GV, CLCT and SNSS Investors to Contact Law Firm

PR Newswire December 1, 2020

SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Sunesis Pharmaceuticals, Inc. Merger

GlobeNewswire December 1, 2020

SHAREHOLDER ALERT: Halper Sadeh LLP Reminds Shareholders About Its Ongoing Merger Investigations; Investors are Encouraged to Contact the Firm - CLCT, INFO, SNSS, RESI, CIT

PR Newswire December 1, 2020

SHAREHOLDER ALERT: WeissLaw LLP Investigates Sunesis Pharmaceuticals, Inc.

PR Newswire November 30, 2020

SHAREHOLDER NOTICE: Brodsky & Smith, LLC Announces an Investigation of Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS)

ACCESSWIRE IA November 30, 2020

SUNESIS ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of SNSS and Encourages Investors to Contact the Firm

GlobeNewswire November 30, 2020

Sunesis Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Merger of Sunesis Pharmaceuticals, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm - SNSS

Business Wire November 30, 2020

Sunesis Pharmaceuticals and Viracta Therapeutics Announce Definitive Merger Agreement

GlobeNewswire November 30, 2020

Sunesis Pharmaceuticals Reports Third Quarter 2020 Financial Results and Recent Highlights

GlobeNewswire November 16, 2020